Due to their limited ability to self-repair, the regeneration of injured tendons is a major challenge in orthopaedics. Tissue engineering has become a popular therapy option for tendons that have been injured. To manufacture cell-laden tissue constructions for implantation, the traditional tissue engineering technique depends on the utilization of culture-expanded patient's own cells and natural and/or synthetic biomaterial scaffolds. This strategy, however, has significant drawbacks, including donor-tissue morbidity, the requirement for a large number of immune-acceptable cells, the protracted in vitro production cycle of designed tissues, and the difficulty associated with long-term storage and preservation of created tissues. The practical deployment of engineered tendon constructs to treat injured tendons using the traditional tissue engineering technique has been hampered by these drawbacks. One of the emerging options is chemical modification of polymeric scaffold surfaces, which allows for improved biocompatibility while also serving as a protein delivery vehicle. Physical adsorption, radiation-mediated modifications, grafting, and protein modifications are all examples of successful strategies for changing the surface properties of polymeric scaffolds.
Title : Side effect free cancer chemotherapy by directed gene delivery using nanomaterials
A C Matin, Stanford University School of Medicine, United States
Title : Artificial intelligence (AI) in biomedical engineering
Hossein Hosseinkhani, Innovation Center for Advanced Technology, Matrix HT, United States
Title : Novel gene therapy options for pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : 30,000 nano implants in humans with no infections, no loosening, and no failures
Thomas J Webster, Hebei University of Technology, China
Title : Challenges in skeletal tissue engineering
Patrizia Ferretti, UCL Great Ormond Street Institute of Child Health, United Kingdom
Title : Electroactive polymer-based smart scaffolds for tissue engineering and regenerative medicine
Federico Carpi, University of Florence, Italy